BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27993643)

  • 1. Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction.
    Parry TJ; Ganguly A; Troy EL; Luis Guerrero J; Iaci JF; Srinivas M; Vecchione AM; Button DC; Hackett CS; Zolty R; Sawyer DB; Caggiano AO
    Eur J Pharmacol; 2017 Feb; 796():76-89. PubMed ID: 27993643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
    Hill MF; Patel AV; Murphy A; Smith HM; Galindo CL; Pentassuglia L; Peng X; Lenneman CG; Odiete O; Friedman DB; Kronenberg MW; Zheng S; Zhao Z; Song Y; Harrell FE; Srinivas M; Ganguly A; Iaci J; Parry TJ; Caggiano AO; Sawyer DB
    PLoS One; 2013; 8(2):e55741. PubMed ID: 23437060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
    Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
    J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure.
    Huang Z; Sawyer DB; Troy EL; McEwen C; Cleator JH; Murphy A; Caggiano AO; Eisen A; Parry TJ
    Toxicol Appl Pharmacol; 2017 Oct; 332():92-99. PubMed ID: 28780372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
    Odiete O; Konik EA; Sawyer DB; Hill MF
    Cardiovasc Diabetol; 2013 Mar; 12():52. PubMed ID: 23530877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.
    Iaci JF; Parry TJ; Huang Z; Pavlopoulos E; Finklestein SP; Ren J; Caggiano A
    J Neurosci Res; 2016 Mar; 94(3):253-65. PubMed ID: 26660233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
    Iaci JF; Ganguly A; Finklestein SP; Parry TJ; Ren J; Saha S; Sietsma DK; Srinivas M; Vecchione AM; Caggiano AO
    Neuropharmacology; 2010 Dec; 59(7-8):640-9. PubMed ID: 20691195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway.
    Shoop S; Maria Z; Campolo A; Rashdan N; Martin D; Lovern P; Lacombe VA
    Front Physiol; 2019; 10():189. PubMed ID: 30971932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
    Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
    J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa).
    Mosedale M; Button D; Jackson JP; Freeman KM; Brouwer KR; Caggiano AO; Eisen A; Iaci JF; Parry TJ; Stanulis R; Srinivas M; Watkins PB
    Toxicol Sci; 2018 Feb; 161(2):401-411. PubMed ID: 29069498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
    Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure.
    Matsukawa R; Hirooka Y; Ito K; Honda N; Sunagawa K
    J Hypertens; 2014 Apr; 32(4):817-25. PubMed ID: 24406781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure.
    Guo YF; Zhang XX; Liu Y; Duan HY; Jie BZ; Wu XS
    Chin Med J (Engl); 2012 Mar; 125(5):807-14. PubMed ID: 22490579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.
    Leosco D; Rengo G; Iaccarino G; Golino L; Marchese M; Fortunato F; Zincarelli C; Sanzari E; Ciccarelli M; Galasso G; Altobelli GG; Conti V; Matrone G; Cimini V; Ferrara N; Filippelli A; Koch WJ; Rengo F
    Cardiovasc Res; 2008 May; 78(2):385-94. PubMed ID: 18093988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.
    Saeed M; Watzinger N; Krombach GA; Lund GK; Wendland MF; Chujo M; Higgins CB
    Radiology; 2002 Sep; 224(3):830-7. PubMed ID: 12202722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
    Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.
    Ryzhov S; Matafonov A; Galindo CL; Zhang Q; Tran TL; Lenihan DJ; Lenneman CG; Feoktistov I; Sawyer DB
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H907-H918. PubMed ID: 28235789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.